List of Excipients in API theophylline anhydrous
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing theophylline anhydrous
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| B Braun Medical Inc | THEOPHYLLINE IN DEXTROSE | theophylline anhydrous and dextrose | 0264-9554 | WATER | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing theophylline anhydrous
Detailed excipient profiles for theophylline anhydrous
Excipient focus: ALCOHOL
theophylline anhydrous drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Pharmaceutical Associates Inc | theophylline anhydrous | 0121-4794 |
| Carilion Materials Management | theophylline anhydrous | 68151-0644 |
| Nostrum Laboratories Inc | theophylline anhydrous | 70408-644 |
| >Company | >Ingredient | >NDC |
theophylline anhydrous drug variants not containing ALCOHOL
Excipient focus: ANHYDROUS CITRIC ACID
theophylline anhydrous drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | theophylline anhydrous | 10135-604 |
| Carilion Materials Management | theophylline anhydrous | 68151-0644 |
| Nostrum Laboratories Inc | theophylline anhydrous | 70408-644 |
| >Company | >Ingredient | >NDC |
theophylline anhydrous drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: CETOSTEARYL ALCOHOL
theophylline anhydrous drug variants containing CETOSTEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Purdue Pharmaceutical Products LP | theophylline anhydrous | 67781-251 |
| >Company | >Ingredient | >NDC |
theophylline anhydrous drug variants not containing CETOSTEARYL ALCOHOL
Excipient focus: CITRIC ACID MONOHYDRATE
theophylline anhydrous drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmaceutical Associates Inc | theophylline anhydrous | 0121-4794 |
| Atlantic Biologicals Corps | theophylline anhydrous | 17856-0644 |
| >Company | >Ingredient | >NDC |
theophylline anhydrous drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: FD&C RED NO. 40
theophylline anhydrous drug variants containing FD&C RED NO. 40
theophylline anhydrous drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Rhodes Pharmaceuticals | theophylline anhydrous | 42858-700 |
| Purdue Pharmaceutical Products LP | theophylline anhydrous | 67781-251 |
| B Braun Medical Inc | theophylline anhydrous and dextrose | 0264-9554 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
theophylline anhydrous drug variants containing GLYCERIN
theophylline anhydrous drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Rhodes Pharmaceuticals | theophylline anhydrous | 42858-700 |
| Purdue Pharmaceutical Products LP | theophylline anhydrous | 67781-251 |
| B Braun Medical Inc | theophylline anhydrous and dextrose | 0264-9554 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYETHYL CELLULOSE
theophylline anhydrous drug variants containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Purdue Pharmaceutical Products LP | theophylline anhydrous | 67781-251 |
| >Company | >Ingredient | >NDC |
theophylline anhydrous drug variants not containing HYDROXYETHYL CELLULOSE
Excipient focus: HYPROMELLOSE 2910
theophylline anhydrous drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Rhodes Pharmaceuticals | theophylline anhydrous | 42858-700 |
| >Company | >Ingredient | >NDC |
theophylline anhydrous drug variants not containing HYPROMELLOSE 2910
Excipient focus: LACTOSE MONOHYDRATE
theophylline anhydrous drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Rhodes Pharmaceuticals | theophylline anhydrous | 42858-700 |
| >Company | >Ingredient | >NDC |
theophylline anhydrous drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
theophylline anhydrous drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Rhodes Pharmaceuticals | theophylline anhydrous | 42858-700 |
| Purdue Pharmaceutical Products LP | theophylline anhydrous | 67781-251 |
| >Company | >Ingredient | >NDC |
theophylline anhydrous drug variants not containing MAGNESIUM STEARATE
Excipient focus: POVIDONE
theophylline anhydrous drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Purdue Pharmaceutical Products LP | theophylline anhydrous | 67781-251 |
| >Company | >Ingredient | >NDC |
theophylline anhydrous drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
theophylline anhydrous drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Rhodes Pharmaceuticals | theophylline anhydrous | 42858-700 |
| >Company | >Ingredient | >NDC |
theophylline anhydrous drug variants not containing POVIDONE K30
Excipient focus: PROPYLENE GLYCOL
theophylline anhydrous drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | theophylline anhydrous | 10135-604 |
| >Company | >Ingredient | >NDC |
theophylline anhydrous drug variants not containing PROPYLENE GLYCOL
Excipient focus: SACCHARIN SODIUM
theophylline anhydrous drug variants containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | theophylline anhydrous | 10135-604 |
| Atlantic Biologicals Corps | theophylline anhydrous | 17856-0644 |
| Carilion Materials Management | theophylline anhydrous | 68151-0644 |
| Nostrum Laboratories Inc | theophylline anhydrous | 70408-644 |
| >Company | >Ingredient | >NDC |
theophylline anhydrous drug variants not containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Pharmaceutical Associates Inc | theophylline anhydrous | 0121-4794 |
| Rhodes Pharmaceuticals | theophylline anhydrous | 42858-700 |
| Purdue Pharmaceutical Products LP | theophylline anhydrous | 67781-251 |
| B Braun Medical Inc | theophylline anhydrous and dextrose | 0264-9554 |
| >Company | >Ingredient | >NDC |
Excipient focus: SACCHARIN SODIUM DIHYDRATE
theophylline anhydrous drug variants containing SACCHARIN SODIUM DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmaceutical Associates Inc | theophylline anhydrous | 0121-4794 |
| >Company | >Ingredient | >NDC |
theophylline anhydrous drug variants not containing SACCHARIN SODIUM DIHYDRATE
Excipient focus: SILICON DIOXIDE
theophylline anhydrous drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Rhodes Pharmaceuticals | theophylline anhydrous | 42858-700 |
| >Company | >Ingredient | >NDC |
theophylline anhydrous drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM BENZOATE
theophylline anhydrous drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | theophylline anhydrous | 10135-604 |
| >Company | >Ingredient | >NDC |
theophylline anhydrous drug variants not containing SODIUM BENZOATE
Excipient focus: TALC
theophylline anhydrous drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Purdue Pharmaceutical Products LP | theophylline anhydrous | 67781-251 |
| >Company | >Ingredient | >NDC |
theophylline anhydrous drug variants not containing TALC
Excipient focus: WATER
theophylline anhydrous drug variants containing WATER
theophylline anhydrous drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Rhodes Pharmaceuticals | theophylline anhydrous | 42858-700 |
| Purdue Pharmaceutical Products LP | theophylline anhydrous | 67781-251 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
